News

NEWS
Press-Release
Software
April 6, 2023
InSysBio to release Immune Response Template 3.6.2 for QSP modeling

The usability of search within IRT is enhanced

InSysBio launches Immune Response Template (IRT) version 3.6.2. IRT update focuses on usability and efficiency of search for information on the platform.
LEARN MORE
NEWS
Publication
January 16, 2023
InSysBio team to publish the new article “Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study”
The new article by Dmitry Shchelokov and Oleg Demin Jr was published in mAbs journal at the end of December 2022
LEARN MORE
NEWS
Press-Release
Software
December 14, 2022
InSysBio to release Immune Response Template for QSP modeling in Oncology

IRT Onco version is focused on tumor-specific immune response

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.
LEARN MORE
NEWS
Press-Release
November 9, 2022
InSysBio to start the operation of new Headquarters and new branch office
InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.
LEARN MORE
NEWS
Publication
July 11, 2022
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
The new article "Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis" by Galina Kolesova, Alexander Stepanov, Galina Lebedeva and Oleg Demin has been recently published.
LEARN MORE
NEWS
Press-Release
May 24, 2022
InSysBio to establish a new legal entity in Cyprus
InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.
LEARN MORE
April 2023
MoTuWeThFrSaSu
     
1
2
3
4
5
6
1. 06 Apr 2023 13:20 The usability of search within IRT is enhanced InSysBio launches Immune Response Template (IRT) version 3.6.2. IRT update focuses on usability and efficiency of search for information on the platform.
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Upcoming Events
02.10
InSysBio to participate in World Bispecific Summit 2023
Tags